Showing results (841-850 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|December 2, 1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentS Rae, J M Raboud, B Conway, et al.AIDS (London, England)|January 1, 1996
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infectionL Meroni, D Trabattoni, C Balotta, et al.AIDS (London, England)|January 1, 1996
Syncytium-inducing phenotype and zidovudine susceptibility of HIV-1 isolated from post-mortem tissueC H McGavin, S A Land, K L Sebire, et al.AIDS (London, England)|October 9, 1998
Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progressionL Xiao, D L Rudolph, S M Owen, et al.AIDS (London, England)|October 9, 1998
Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurementsJ L Fahey, J M Taylor, B Manna, et al.AIDS (London, England)|October 9, 1998
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infectionP Carotenuto, D Looij, L Keldermans, et al.AIDS (London, England)|October 9, 1998
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infectionA d'Arminio Monforte, L Testa, F Adorni, et al.AIDS (London, England)|October 9, 1998
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infectionA Cozzi Lepri, T L Katzenstein, H Ullum, et al.AIDS (London, England)|May 1, 1993
Barrier contraceptive use and HIV infection among high-risk women in CameroonL Zekeng, P J Feldblum, R M Oliver, et al.AIDS (London, England)|April 1, 1993
Antigenic variation of the dominant gp41 epitope in AfricaJ M Lange, V J Teeuwsen, C A Boucher, et al.Pageof 1,044